135 related articles for article (PubMed ID: 16170771)
1. Breakthrough zygomycosis and voriconazole.
Pagano L; Gleissner B; Fianchi L
J Infect Dis; 2005 Oct; 192(8):1496-7; author reply 1497. PubMed ID: 16170771
[No Abstract] [Full Text] [Related]
2. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
Marty FM; Cosimi LA; Baden LR
N Engl J Med; 2004 Feb; 350(9):950-2. PubMed ID: 14985500
[No Abstract] [Full Text] [Related]
3. [Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
Salavert M; Jarque I
Rev Esp Quimioter; 2006 Mar; 19(1):11-3. PubMed ID: 16688286
[No Abstract] [Full Text] [Related]
4. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.
Siwek GT; Dodgson KJ; de Magalhaes-Silverman M; Bartelt LA; Kilborn SB; Hoth PL; Diekema DJ; Pfaller MA
Clin Infect Dis; 2004 Aug; 39(4):584-7. PubMed ID: 15356827
[TBL] [Abstract][Full Text] [Related]
5. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
Vigouroux S; Morin O; Moreau P; Méchinaud F; Morineau N; Mahé B; Chevallier P; Guillaume T; Dubruille V; Harousseau JL; Milpied N
Clin Infect Dis; 2005 Feb; 40(4):e35-7. PubMed ID: 15712069
[TBL] [Abstract][Full Text] [Related]
6. Zygomycete infection following voriconazole prophylaxis.
van Well GT; van Groeningen I; Debets-Ossenkopp YJ; van Furth AM; Zwaan CM
Lancet Infect Dis; 2005 Sep; 5(9):594. PubMed ID: 16122683
[No Abstract] [Full Text] [Related]
7. Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia.
Oren I
Clin Infect Dis; 2005 Mar; 40(5):770-1. PubMed ID: 15714432
[No Abstract] [Full Text] [Related]
8. Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child.
Ritz N; Ammann RA; Aebischer CC; Gugger M; Jaton K; Schmid RA; Aebi C
Eur J Pediatr; 2005 Apr; 164(4):231-5. PubMed ID: 15633048
[TBL] [Abstract][Full Text] [Related]
9. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
Trifilio S; Singhal S; Williams S; Frankfurt O; Gordon L; Evens A; Winter J; Tallman M; Pi J; Mehta J
Bone Marrow Transplant; 2007 Sep; 40(5):451-6. PubMed ID: 17589527
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
Pongas GN; Lewis RE; Samonis G; Kontoyiannis DP
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():93-7. PubMed ID: 19754766
[TBL] [Abstract][Full Text] [Related]
11. Nasofacial phycomycosis: persistence pays.
Moore MH; Murphy D; James C
J Craniofac Surg; 2007 Mar; 18(2):448-50. PubMed ID: 17414301
[TBL] [Abstract][Full Text] [Related]
12. Sinus zygomycosis in a patient receiving voriconazole prophylaxis.
Lionakis MS; Kontoyiannis DP
Br J Haematol; 2005 Apr; 129(1):2. PubMed ID: 15801950
[No Abstract] [Full Text] [Related]
13. Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy.
Kim MS; Lee HM; Sung HS; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Int J Dermatol; 2012 May; 51(5):621-3. PubMed ID: 21790547
[No Abstract] [Full Text] [Related]
14. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient.
Tong SY; Peleg AY; Yoong J; Handke R; Szer J; Slavin M
Transpl Infect Dis; 2007 Sep; 9(3):241-3. PubMed ID: 17605752
[TBL] [Abstract][Full Text] [Related]
15. Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
Sagnelli C; Fumagalli L; Prigitano A; Baccari P; Magnani P; Lazzarin A
J Antimicrob Chemother; 2006 Apr; 57(4):796-8. PubMed ID: 16469850
[No Abstract] [Full Text] [Related]
16. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
Kobayashi K; Kami M; Murashige N; Kishi Y; Fujisaki G; Mitamura T
Haematologica; 2004 Nov; 89(11):ECR42. PubMed ID: 15533847
[No Abstract] [Full Text] [Related]
17. Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole.
Matsumoto Y; Oh-I T; Nagai A; Ohyama F; Ooishi T; Tsuboi R
J Dermatol; 2009 Feb; 36(2):98-102. PubMed ID: 19284454
[TBL] [Abstract][Full Text] [Related]
18. Emerging importance of infections due to zygomycetes in organ transplant recipients.
Sun HY; Singh N
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S115-8. PubMed ID: 19013334
[TBL] [Abstract][Full Text] [Related]
19. Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
Uriz J; de Andoin NG; Calvo C; Landa J; Onate E; Nogues A; Guerrero R
Pediatr Infect Dis J; 2007 Oct; 26(10):971-2. PubMed ID: 17901816
[No Abstract] [Full Text] [Related]
20. The safety of voriconazole.
Potoski BA; Brown J
Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
